Home - Translational Lung Cancer Research

AME and Wolters Kluwer aim to expand access to global medical research through new collaboration

The agreement broadens the reach of nearly 50 Open Access titles, contributing globally to over 5,000 articles

October 2, 2025 — Wolters Kluwer Health announced a new collaboration with AME Publishing Company, an Open Access publisher specializing in medical journals and books, headquartered in Hong Kong, China.

New Impact Factor for Translational Lung Cancer Research: 3.5

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2024 citation year: 3.5.

Translational Lung Cancer Research 2024 CiteScore Released: 6.9

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has achieved its 2024 CiteScore: 6.9, ranking 92 out of 415 journals in the Oncology category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

Interviews with Outstanding Authors (2025)

In 2025, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2025)

In 2025, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

TLCR Annual Report 2024

Welcome to the 2024 annual report for Translational Lung Cancer Research. In 2024, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2024, and we look forward to continuing our work with you in the new year.

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

‹ ›

Vol 14, No 11 (November, 2025)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Editorial Commentary

Perioperative chemo immunotherapy in non-small-cell lung cancer: what can we learn from the long-term results of NADIM?

Xavier Fremand, Ilaria Onorati, Boris Duchemann

PDF Pages: 4704-4710 Full Text (89) Peer Review File COI Form Open Access

Letetresgene autoleucel in advanced non-small cell lung cancer: a step towards truly personalized immunotherapy?

M. Alejandra Molina-Pérez, Sergio Martínez-Recio, Andrés Barba, Mikel Portu, Judit Sanz-Beltran, Margarita Majem

PDF Pages: 4711-4714 Full Text (53) Peer Review File COI Form Open Access

T cell receptor (TCR)-based therapy in advanced non-small cell lung cancer: a new hope?

Adrien Costantini, Etienne Giroux Leprieur

PDF Pages: 4715-4718 Full Text (51) Peer Review File COI Form Open Access

Original Article

Defining the surgical curative time window: identifying patients with an absence of recurrence for 5 years following surgical resection of stage I invasive non-small cell lung cancer

Tong Li, Yang Zhang, Hong Hu, Ting Ye, Yihua Sun, Yawei Zhang, Jiaqing Xiang, Haiquan Chen

PDF Pages: 4719-4732 Full Text (90) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy

Yusuke Kunimatsu, Naoya Nishioka, Tadaaki Yamada, Hayato Kawachi, Motohiro Tamiya, Yoshiki Negi, Yasuhiro Goto, Akira Nakao, Shinsuke Shiotsu, Keiko Tanimura, Takayuki Takeda, Asuka Okada, Taishi Harada, Koji Date, Yusuke Chihara, Isao Hasegawa, Nobuyo Tamiya, Masaki Ishida, Takashi Kijima, Koichi Takayama

PDF Pages: 4733-4745 Full Text (97) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Integrative modeling of longitudinal cell-free DNA and tumor volume dynamics: a multimodal quantitative prognostic framework

Jihwan Choi, Jooyong Shim, Jonghoon Kim, Yeon Jeong Kim, Changha Hwang, Woong-Yang Park, Jae Myoung Noh, Hongryull Pyo, Ho Yun Lee

PDF Pages: 4746-4755 Full Text (70) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301

Fumihiko Okumura, Hisashi Tanaka, Katsuhiro Onodera, Ryo Morita, Minehiko Inomata, Aya Suzuki, Jun Sugisaka, Hiroyuki Minemura, Daisuke Jingu, Satoshi Kudo, Hajime Kikuchi, Naruo Yoshimura, Fumiyasu Tsushima, Shingo Kakeda, Sadatomo Tasaka

PDF Pages: 4756-4767 Full Text (71) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Deep structural lipidomic profiling reveals C=C positional isomers as potential biomarkers in lung adenocarcinoma tissue

Yang Gu, Ming-Ming Shao, Song-Ping Cui, Bin Hu, Xin Li

PDF Pages: 4768-4783 Full Text (67) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Subtype-specific RNA sequencing using micro-dissection revealed extracellular matrix alterations as key factors in lung adenocarcinoma invasion

Chongze Yuan, Xiao Chen, Yizhou Peng, Qiang Zheng, Yunjian Pan, Xuxia Shen, Xiaoting Tao, Xingxin Yao, Hui Hong, Hongbin Ji, Yawei Zhang, Yihua Sun

PDF Pages: 4784-4795 Full Text (48) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Treatment interruption during neoadjuvant immuno-chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

Yi Liu, Zhihao Wang, Shuxiao Ma, Zhenyu Yang, Yile Li, Abuduwaili Yasheng, Zelin Deng, Zheng Liu, Chuan Li, Liang Xia, Lugang Zhou, Chengwu Liu

PDF Pages: 4796-4810 Full Text (55) Reporting Checklist Peer Review File COI Form Open Access

Real-world first-line outcomes of alectinib and brigatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: a nationwide South Korean cohort study using the health insurance review and assessment data

Hee Jun Kim, Eunyoung Angela Lee, Jin-Hee Park, Hyun Woo Lee

PDF Pages: 4811-4823 Full Text (61) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic impact of ALK rearrangement in surgically treated stage I lung adenocarcinoma: a retrospective cohort study

Yuchen Huang, Jian Zhou, Cheng Shen, Ruijia Yang, Quan Zheng, Yang Qiu, Xiaoli Mei, Kunhao Wu, Dongsheng Wu, Jinghan Wang, Wenjing Jiang, Hu Liao

PDF Pages: 4824-4837 Full Text (41) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancer

Birgit Hantzsch-Kuhn, Nina Schraps, Martin Reck, Sönke von Weihe, Till Olchers, David Benjamin Ellebrecht, Katharina Moeller, Christoph Fraune, Maximilian Lennartz, Florian Lutz, Martina Kluth, Georgia Makrypidi-Fraune, Ronald Simon, Guido Sauter, Stefan Steurer

PDF Pages: 4838-4848 Full Text (57) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Comparative effectiveness and safety of systemic therapies for treatment-naïve, PD-L1 expression <1% advanced NSCLC: a systematic review and network meta-analysis

Mengyun Zhou, Junfang Huang, Zhou Jin, Qingqing Hao, Xueying Li, Kunyao Yu, Kunyan Sun, Xiang Zhao, Meng Zhang, Guangfa Wang, Yuan Cheng

PDF Pages: 4849-4867 Full Text (67) Reporting Checklist Peer Review File COI Form Open Access

Establishment and characterization of an orthotopic implanted lung cancer model to mimic human tumor structure, microenvironment, and metastatic spread

Beñat Picabea, Daniel Orive, Covadonga Rodríguez, Miren Mailharin, María Sangüesa, Maeva Houry, Andrea Arricibita, Mirari Echepare, Ane Álava, Cristina Viu-Idocin, Alfonso Calvo, Joaquín Fernández-Irigoyen, Enrique Santamaría, Mikel Ariz, Luis M. Montuenga, Karmele Valencia

PDF Pages: 4868-4895 Full Text (Video) (88) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Is seeing believing?—signal differentiation in a preclinical transbronchial imaging study implementing a composite optical fiber bronchoscope to detect a folate receptor-targeted near-infrared fluorophore

Yoshihisa Hiraishi, Tsukasa Ishiwata, Theodore Husby, Yuki Sata, Alexander Gregor, Takamasa Koga, Hiroyuki Ogawa, Shinsuke Kitazawa, Fumi Yokote, Masato Aragaki, Kate Kazlovich, Andrew Effat, Nicholas Bernards, Hidenori Kage, Brian C. Wilson, Kazuhiro Yasufuku

PDF Pages: 4896-4905 Full Text (Video) (53) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Whole genome characterization of patient-derived lung cancer organoids

Hoi-Hin Kwok, Nerissa Chui-Mei Lee, Junyang Deng, Jiashuang Yang, Lynn Yim-Wah Shong, Cally Ka-Lai Ho, Kwok-Fai Lee, Michael Kuan-Yew Hsin, Hongjing Zang, Joshua Jing-Xi Li, David Chi-Leung Lam

PDF Pages: 4906-4922 Full Text (63) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

PD-L1 expression in primary lung tumor as a superior predictive biomarker to metastatic lymph nodes for first-line immunochemotherapy in advanced KRAS-mutant non-small cell lung cancer

Hongping Jin, Yidan Zhang, Honglei Huang, Jianlin Xu, Yingqi Xu, Yiqing Wu, Tengfei Liu, Hua Zhong, Jie Chen, Qian Miao, Runbo Zhong

PDF Pages: 4923-4941 Full Text (59) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Stage- and smoking-associated microRNA expression in lung adenocarcinoma

Min Huang, Yimin Ge, Huiqin Chen, Caimiao Wei, David Cogdell, Cristina Ivan, Meng Chen, Wei Zhang, George A. Calin, Ming Guo

PDF Pages: 4942-4961 Full Text (75) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancer

Mary E. Gwin, Mitchell S. von Itzstein, Jialiang Liu, Farjana J. Fattah, Hong Mu-Mosley, Jeffrey A. SoRelle, Sheena Bhalla, Jonathan E. Dowell, Sawsan Rashdan, Jason Y. Park, Donghan M. Yang, Yang Xie, David E. Gerber

PDF Pages: 4962-4972 Full Text (50) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience

Ji Won Lee, Yoon Ji Choi, Jung Sun Kim, Eun Joo Kang, Mi Sun Ahn, Yu Jung Kim, Seong Yoon Yi, Seungtaek Lim, Ji Yoon Lee, Ju Won Kim, Sang Won Shin, Yeul Hong Kim

PDF Pages: 4973-4982 Full Text (54) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers

Wensheng Zhou, Yujie Tang, Jiyuan Zeng, Xiaoyi Zhang, Haotian Meng, Wenhui Guan, Yue Zhu, Huixin Jiang, Yansheng Wang, Xiaohong Xie, Chengzhi Zhou, Ming Liu

PDF Pages: 4983-4999 Full Text (77) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Immune checkpoint inhibitors have limited efficacy in SMARCA4-deficient non-small cell lung cancer

Ying Han, Jing Wang, Boyue Pang, Jiali Zhang, Xiaoliang Zhao, Shuan Hao, Qiang Zhang, Xiubao Ren, Leina Sun

PDF Pages: 5000-5016 Full Text (51) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Comparison of efficacy and surgery-related safety of perioperative tislelizumab and pembrolizumab with neoadjuvant chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study

Yizhang Li, Jialing Jiang, Xin Yao, Zhaoyang Wang, Changjian Shao, Jian Wang, Jie Lei, Jinbo Zhao, Masaya Aoki, Hiroyuki Adachi, Yunfeng Ni, Yong Liu, Hongtao Duan, Xiaolong Yan

PDF Pages: 5017-5030 Full Text (41) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

c-MET expression and immune landscape in locally advanced patients with non-small cell lung cancer undergoing radiochemotherapy and consolidative immunotherapy

Lisha Ye, Xiaoling Xu, Ying Zhang, Wei Zhang, Leilei Wu, Chunyan Wu, Yaoyao Zhu, Yaping Xu

PDF Pages: 5031-5043 Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study

Haoran Zhang, Zhaozhen Wu, Tao Lu, Hui Zhang, Ji Li, Dongming Zhang, Siyuan Yu, Xiaobei Guo, Xiaoyi Feng, Jia Liu, Yuequan Shi, Xiaoxing Gao, Xiaoyan Liu, Minjiang Chen, Jing Zhao, Wei Zhong, Ying Hu, Yan Xu, Mengzhao Wang

PDF Pages: 5044-5058 Full Text (54) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Development and validation of a multivariable prognostic model incorporating black-blood magnetic resonance imaging-based meningeal lymphatic remodeling to predict therapy response in non-small cell lung cancer brain metastases

Wei Shao, Zongbo Li, Feng Qiu, Hengsen Zhang, Shudong Hu, Yifan Liu, Duoduo Li, Yuxi Ge, Hua Lu

PDF Pages: 5059-5073 Full Text (46) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Brief Report

Circulating stem-like exhausted CD8 T cells point to better outcomes in lung cancer: a brief report

Linda Ye, Ian Dick, Tina Firth, Bruce W. Robinson, Jenette Creaney, Alec Redwood

PDF Pages: 5074-5081 Full Text (66) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Redefining treatment interval in lung cancer surgery in the era of prehabilitation: a systematic review

Lisa D. Geomini, Quirine C. A. van Steenwijk, Shiromani Janki, Iris Hoogendoorn, Gerrit D. Slooter, Frank J. C. van den Broek, Geertruid M. H. Marres

PDF Pages: 5082-5098 Full Text (151) Reporting Checklist Peer Review File COI Form Open Access

Exosomal biomarkers and therapeutics in lung cancer: a narrative review on their role in early detection and targeted treatment

Jorge Rodríguez-Sanz, Elisa Mincholé Lapuente, Dinora Polanco Alonso, Manuel David Viñuales Aranda, Marta Marín-Oto, Juan Antonio Domingo Morera, José María Marín Trigo, David Sanz-Rubio

PDF Pages: 5099-5117 Full Text (65) Reporting Checklist Peer Review File COI Form Open Access

A narrative review of pathologic response in non-small cell lung cancer: challenges, implications, and future directions

Yuan Li, Fei Liang, Suijun Xiao, Chao Yuan, Haiquan Chen

PDF Pages: 5118-5136 Full Text (70) Reporting Checklist Peer Review File COI Form Open Access

The pathogenesis and therapeutic management of rare pulmonary sarcomatoid carcinoma: a narrative review

Qianyi Wang, Haoyue Guo, Yuanyuan Wang, Taiping He, Meng Diao, Yuhan Wu, Anwen Xiong, Fei Zhou, Wei Li, Lei Cheng, Chao Zhao, Xuefei Li, Caicun Zhou

PDF Pages: 5137-5158 Full Text (46) Reporting Checklist Peer Review File COI Form Open Access

Robotic-assisted and electromagnetic navigation bronchoscopy for multi-focal lung cancers: a narrative review

Wei Liu, Aliss T. C. Chang, Joyce W. Y. Chan, Rainbow W. H. Lau, Tony S. K. Mok, Calvin S. H. Ng

PDF Pages: 5159-5180 Full Text (41) Reporting Checklist Peer Review File COI Form Open Access

Decoding the enigma of multiple primary lung cancers: from mechanism to bedside—a narrative review

Pan Yang, Siyu Liu, Yuansi Chen, Yihan Guo, Yi Li, Zhen Wang, Weimin Li, Zhoufeng Wang

PDF Pages: 5181-5197 Full Text (43) Reporting Checklist Peer Review File COI Form Open Access

Letter to the Editor

A new hope for aggressive thoracic cancers: foundational efficacy of frontline immunotherapy in SMARCA4-deficient tumors

Qiang Wu, Li Wang, Hao Su, Ting Lei

PDF Pages: 5198-5199 Full Text (52) COI Form Open Access

Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerations

Beibei Liu, Danni Wang, Yujing Li, Fangfei Qian, Yanwei Zhang, Lele Zhang, Xinwei Wu, Xuemei Liu, Wenyan Ma, Wei Zhang, Lvkan Weng, Yuqing Lou, Rong Li

PDF Pages: 5200-5202 Full Text (36) COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Pages: 354-363 Full Text (338926) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Pages: S425-S427 Full Text (88120) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Pages: 288-300 Full Text (79192) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Pages: 40-49 Full Text (70426) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Pages: 68-75 Full Text (60665) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Pages: 242-249 Full Text (48347) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Pages: 302-316 Full Text (44609) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Pages: 36-54 Full Text (43548) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Pages: 304-312 Full Text (43014) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Pages: 487-497 Full Text (40672) Chinese (6006) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Pages: 253-264 Full Text (39589) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Pages: 220-233 Full Text (34697) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Pages: 288-303 Full Text (33764) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Pages: 508-512 Full Text (32571) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Pages: 142-151 Full Text (32471) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Pages: 286-301 Full Text (32409) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Pages: 3503-3519 Full Text (30814) COI Form Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Pages: 156-164 Full Text (29713) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Pages: 14-25 Full Text (29045) Open Access

Review Articles

New TNM classification: achievements and hurdles

Peter Goldstraw

Published online: 17 August 2013

PDF Pages: 264-272 Full Text (29045) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Currently no content available!

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.